United States, Feb. 12 -- Contract Research Organizations (CROs) continue to rely on Oracle to keep pace with competitive pressures, changing market requirements, and a lack of skilled talent. Since its inception in summer 2022, numerous CROs have joined the Oracle CRO growth initiative, including recent entrants AMS Advanced Medical Services GmbH, Firma Clinical, and EPS Corp., among many others. Through the initiative, CROs can evaluate, familiarize, train, and enable their users with Oracle Clinical One and demonstrate the power of the platform with their potential sponsors. This winning combination of Oracle's life sciences expertise and platform technology help CROs win more business and run trials more efficiently.
As part of the CRO...